At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02367 GIANT BIOGENE
Not Yet Opened 12-22 16:08:10
36.060
+0.580
+1.63%
High36.360Low35.500Vol5.35M
Open35.580D1 Closing35.480Amplitude2.42%
Mkt Cap38.62BTradable Cap38.62BTotal Shares1.07B
T/O192.25MT/O Rate0.50%Tradable Shares1.07B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
HK Stock Buyback Summary | December 18
Stock News  ·  12-18
HK Stock Buyback Summary | December 18
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.97 Million on December 17
Stock News  ·  12-17
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$13.97 Million on December 17
Morgan Stanley Adjusts Giant Biogene Holding's Price Target to HK$42 from HK$78, Keeps at Overweight
MT Newswires Live  ·  12-17
Morgan Stanley Adjusts Giant Biogene Holding's Price Target to HK$42 from HK$78, Keeps at Overweight
Did Giant Biogene’s New Buyback Plan Just Shift Giant Biogene Holding's (SEHK:2367) Investment Narrative?
Simply Wall St.  ·  12-17
Did Giant Biogene’s New Buyback Plan Just Shift Giant Biogene Holding's (SEHK:2367) Investment Narrative?
HKEX Share Buyback Summary | December 17
Stock News  ·  12-17
HKEX Share Buyback Summary | December 17
GIANT BIOGENE (02367) Repurchases 400,000 Shares for Approximately HK$13.92 Million on December 15
Stock News  ·  12-15
GIANT BIOGENE (02367) Repurchases 400,000 Shares for Approximately HK$13.92 Million on December 15
Giant Biogene Holding (SEHK:2367): Valuation Check After New Buyback Plan and Fresh Broker Buy Ratings
Simply Wall St.  ·  12-15
Giant Biogene Holding (SEHK:2367): Valuation Check After New Buyback Plan and Fresh Broker Buy Ratings
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$14.04 Million on December 12
Stock News  ·  12-12
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$14.04 Million on December 12
Hong Kong Stock Buyback Summary | December 12
Stock News  ·  12-12
Hong Kong Stock Buyback Summary | December 12
Hong Kong Stocks Hit 52-Week Highs and Lows | Dec 11
Stock News  ·  12-11
Hong Kong Stocks Hit 52-Week Highs and Lows | Dec 11
HK Stock Movement | GIANT BIOGENE (02367) Falls Over 3% Again as Comfy Faces Short-Term Pressure; Multiple Institutions Cut Earnings Forecasts
Stock News  ·  12-11
HK Stock Movement | GIANT BIOGENE (02367) Falls Over 3% Again as Comfy Faces Short-Term Pressure; Multiple Institutions Cut Earnings Forecasts
CITIC Securities Maintains "Buy" Rating on GIANT BIOGENE (02367) with HK$44 Target Price
Stock News  ·  12-11
CITIC Securities Maintains "Buy" Rating on GIANT BIOGENE (02367) with HK$44 Target Price
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$14.3764 Million on December 9
Stock News  ·  12-09
GIANT BIOGENE (02367) Repurchases 400,000 Shares for HK$14.3764 Million on December 9
CMB International: 2025 Medical Insurance Catalog Continues Support for Innovation, Expects CXO Sector Recovery in H2
Stock News  ·  12-09
CMB International: 2025 Medical Insurance Catalog Continues Support for Innovation, Expects CXO Sector Recovery in H2
HK Stock Movement | GIANT BIOGENE (02367) Falls Nearly 4% as Comfy Sales Under Pressure; Management Lowers Annual Guidance
Stock News  ·  12-08
HK Stock Movement | GIANT BIOGENE (02367) Falls Nearly 4% as Comfy Sales Under Pressure; Management Lowers Annual Guidance
HK Stock Connect Shareholding Changes | December 8
Stock News  ·  12-08
HK Stock Connect Shareholding Changes | December 8
Giant Biogene (02367) Announces No Change in Share Capital for November 2025
Bulletin Express  ·  12-03
Giant Biogene (02367) Announces No Change in Share Capital for November 2025
Jefferies Adjusts Giant Biogene's Price Target to HK$55 From HK$72, Keeps at Buy
MT Newswires Live  ·  12-03
Jefferies Adjusts Giant Biogene's Price Target to HK$55 From HK$72, Keeps at Buy
Giant Biogene's Recovery Drivers Appear Clear to Bull -- Market Talk
Dow Jones  ·  12-03
Giant Biogene's Recovery Drivers Appear Clear to Bull -- Market Talk
HK Stock Movement | GIANT BIOGENE (02367) Drops Over 4% as BofA Notes Weak Double 11 Sales; Management Lowers Guidance
Stock News  ·  12-03
HK Stock Movement | GIANT BIOGENE (02367) Drops Over 4% as BofA Notes Weak Double 11 Sales; Management Lowers Guidance

Introduction

Company Name.
GIANT BIOGENE
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.
Issue price:
--